CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 130 enrolled
Drug / intervention
Novorapid ®, Novo Nordisk, Denmarkdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00353431
NCT00353431N/ACompleted
CompareCT.gov

Evaluation of an Algorithm for Intensive s.c. Insulin Therapy in Emergency Room Patients With Hyperglycaemia

University Hospital, Basel, Switzerland·interventional·Posted Jul 18, 2006·Updated May 18, 2012

In Brief

A clinical study evaluating Novorapid ®, Novo Nordisk, Denmark for Hyperglycemias. Completed, enrolled 130 participants across 1 site.

Detailed Summary

The aim of this study is to test the safety and efficacy of a new algorithm for intensive s.c. insulin injection in medical emergency patients with hyperglycaemia (plasma glucose concentration ≥ 8 mmol/l)

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHyperglycemias
CountriesSwitzerland
Collaborators--

Timeline

N/ACompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJul 18, 2006
Enrollment StartDec 1, 2006
Primary CompletionApr 1, 2010
Study CompletionOct 1, 2010
TodayJul 2, 2026
Enrollment to primary: 3.3 yearsPosted 20.0 years ago

Interventions

Novorapid ®, Novo Nordisk, Denmarkdrug

Comparison of a sliding scale with an intensive s.c. scale